This inventor holds 2 USPTO granted patents. Top assignee: William Marsh Rice University. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: Rohan Diliprao Erande: Innovator in Anticancer Research
Introduction
Rohan Diliprao Erande is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of anticancer research, particularly through his innovative work on tubulysin analogues. With a total of 2 patents, his research focuses on developing new methods and compounds for cancer treatment.
Latest Patents
Rohan's latest patents include "Tubulysin analogues as anticancer agents and payloads for antibody-drug conjugates and methods of treatment therewith." This patent provides tubulysin analogs of a specific formula, along with methods for preparing these compounds and their pharmaceutical applications. Another significant patent is "Desacetoxytubulysin H and analogs thereof," which also details tubulysin analogs and methods for their preparation and use in pharmaceutical compositions.
Career Highlights
Rohan is affiliated with William Marsh Rice University, where he conducts his research and development. His work is pivotal in advancing the understanding and treatment of cancer through innovative drug design.
Collaborations
Rohan has collaborated with esteemed colleagues such as Kyriacos Costa Nicolaou and Dionisios Vourloumis. These collaborations enhance the depth and impact of his research in the scientific community.
Conclusion
Rohan Diliprao Erande is a prominent figure in the field of anticancer research, with a focus on developing innovative treatments through his patented work. His contributions are vital for the advancement of cancer therapies and showcase the importance of innovation in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
